UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

1H and 31P nuclear magnetic resonance studies of the differences in DNA deformation induced by anti-tumoral 7H-pyrido[4,3-c]carbazole dimers

Journal of molecular biology, 1989-11, Vol.210 (1), p.211-228

1989

Volltextzugriff (PDF)

234 Importance of timing for thoracic irradiation (TI) in the combined modality treatment of limited-stage small-cell lung cancer (LSCLC): An update of the National Cancer Institute of Canada (NCIC) BR6 study

Lung cancer (Amsterdam, Netherlands), 1997-08, Vol.18, p.61-61

1997

Volltextzugriff (PDF)

242 Phase I study of irinotecan (I), raltitrexed (R), and 5-fluorouracil (5FU) in the treatment of metastatic colorectal cancer (MCRC) refractory to thymidylate synthase inhibitors (TSI)

European journal of cancer supplements, 2003-09, Vol.1 (5), p.S75-S75

2003

Volltextzugriff (PDF)

278 Functional status during and after adjuvant therapy for colorectal cancer

European journal of cancer supplements, 2003-09, Vol.1 (5), p.S85-S85

2003

Volltextzugriff (PDF)

395 MGCD265, an orally active Met/VEGFR multitargeted kinase inhibitor, in combination with erlotinib: clinical and preclinical experience

European journal of cancer supplements, 2010, Vol.8 (7), p.125-126

2010

Volltextzugriff (PDF)

396 MGCD265, an orally active Met/VEGFR multitargeted kinase inhibitor, in combination with docetaxel: clinical and preclinical experience

European journal of cancer supplements, 2010, Vol.8 (7), p.126-126

2010

Volltextzugriff (PDF)

45 or 50 Gy, Which is the Optimal Radiotherapy Pelvic Dose in Locally Advanced Cervical Cancer in the Perspective of Reaching Magnetic Resonance Image-guided Adaptive Brachytherapy Planning Aims?

Clinical oncology (Royal College of Radiologists (Great Britain)), 2016-03, Vol.28 (3), p.171-177

2016

Volltextzugriff (PDF)

5-Fluorouracil with Folinic Acid is Not Effective Against Metastatic Adenocarcinoma of the Lung

Cancer investigation, 1990, Vol.8 (3-4), p.345-349

1990

Volltextzugriff (PDF)

6998 Giant Pheochromocytoma: A Retrospective Single-Center Study

Journal of the Endocrine Society, 2024-10, Vol.8 (Supplement_1)

2024

Volltextzugriff (PDF)

702PSTANDARD CLINICAL PRACTICE OF FOLFIRINOX (FFX) IN ADVANCED/METASTATIC PANCREATIC CANCER (PC) PATIENTS: A CANADIAN RETROSPECTIVE REGISTRY

Annals of oncology, 2014-09, Vol.25 (suppl_4), p.iv238-iv239

2014

Volltextzugriff (PDF)

Abstract 1790: The combination of MGCD265, a Met/VEGFR inhibitor in clinical development, and erlotinib potently inhibits tumor growth by altering multiple pathways including glycolysis

Cancer research (Chicago, Ill.), 2012-04, Vol.72 (8_Supplement), p.1790-1790

2012

Volltextzugriff (PDF)

Abstract 3609: MGCD265, an orally active Met/VEGFR multitargeted kinase inhibitor in Phase II clinical development, potently inhibits clinically relevant Met mutants

Cancer research (Chicago, Ill.), 2010-04, Vol.70 (8_Supplement), p.3609-3609

2010

Volltextzugriff (PDF)

Abstract 3610: Potent preclinical anti-tumor activity of MGCD265, an oral Met/VEGFR multitargeted kinase inhibitor in clinical development, in combination with taxanes

Cancer research (Chicago, Ill.), 2011-04, Vol.71 (8_Supplement), p.3610-3610

2011

Volltextzugriff (PDF)

Abstract 3612: Potent preclinical anti-tumor activity of MGCD265, an orally active Met/VEGFR multitargeted kinase inhibitor in Phase II clinical development, in combination with an EGFR inhibitor

Cancer research (Chicago, Ill.), 2010-04, Vol.70 (8_Supplement), p.3612-3612

2010

Volltextzugriff (PDF)

Abstract 4681: Inhibition of poly (ADP-ribose) polymerase-1 (PARP-1) as a strategy for targeted therapy in Ewing's sarcoma

Cancer research (Chicago, Ill.), 2012-04, Vol.72 (8_Supplement), p.4681-4681

2012

Volltextzugriff (PDF)

Abstract 930: Preclinical characterization of MG516, a novel inhibitor of receptor tyrosine kinases involved in resistance to targeted therapies

Cancer research (Chicago, Ill.), 2013-04, Vol.73 (8_Supplement), p.930-930

2013

Volltextzugriff (PDF)

Abstract A95: The determination of the maximum tolerated dose (MTD) of MGCD265 on an intermittent schedule: Phase I study results (Study 265-102)

Molecular cancer therapeutics, 2011-11, Vol.10 (11_Supplement), p.A95-A95

2011

Volltextzugriff (PDF)

Abstract No. 124 Quantitative analysis of tissue contraction and volume variability of lung microwave ablation zones

Journal of vascular and interventional radiology, 2022-06, Vol.33 (6), p.S58-S59

2022

Volltextzugriff (PDF)

Acute hypersensitivity of pluripotent testicular cancer-derived embryonal carcinoma to low-dose 5-aza deoxycytidine is associated with global DNA Damage-associated p53 activation, anti-pluripotency and DNA demethylation

PloS one, 2012-12, Vol.7 (12), p.e53003

2012

Volltextzugriff (PDF)

Acute Kidney Injury and Bronchopulmonary Dysplasia in Premature Neonates Born Less than 32 Weeks' Gestation

American journal of perinatology, 2020-02, Vol.37 (3), p.341-348

2020

Volltextzugriff (PDF)

Acute Kidney Injury is Associated with Poor Lung Outcomes in Infants Born ≥32 Weeks of Gestational Age

American journal of perinatology, 2020-01, Vol.37 (2), p.231-240

2020

Volltextzugriff (PDF)

Adjuvant chemotherapy with fluorouracil plus folinic acid vs gemcitabine following pancreatic cancer resection: a randomized controlled trial

JAMA : the journal of the American Medical Association, 2010-09, Vol.304 (10), p.1073

2010

Volltextzugriff (PDF)

ADM1 performance using SS-OFMSW with non-acclimated inoculums

Water science and technology, 2012-01, Vol.66 (9), p.1885-1892

2012

Volltextzugriff (PDF)

Admetal-induced substrate surface restructuring during metal-on-metal electrochemical deposition studied by in situ scanning tunneling microscopy

Surface science, 2000-07, Vol.460 (1), p.249-263

2000

Volltextzugriff (PDF)

Advances in Neonatal Acute Kidney Injury

Pediatrics (Evanston), 2021-11, Vol.148 (5), p.1

2021

Volltextzugriff (PDF)

1 – 25 von 469

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(411)
Mit Volltextzugriff
(406)

Publikationsform

Sprache

1 weiteren anzeigen...

Weniger anzeigen...

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 7 Tagen
(2)
... seit 90 Tagen
(3)

Menü

Weitere Dienste

Einstellungen

1H and 31P nuclear magnetic resonance studies of the differences in DNA deformation induced by anti-tumoral 7H-pyrido[4,3-c]carbazole dimers

234 Importance of timing for thoracic irradiation (TI) in the combined modality treatment of limited-stage small-cell lung cancer (LSCLC): An update of the National Cancer Institute of Canada (NCIC) BR6 study

242 Phase I study of irinotecan (I), raltitrexed (R), and 5-fluorouracil (5FU) in the treatment of metastatic colorectal cancer (MCRC) refractory to thymidylate synthase inhibitors (TSI)

278 Functional status during and after adjuvant therapy for colorectal cancer

395 MGCD265, an orally active Met/VEGFR multitargeted kinase inhibitor, in combination with erlotinib: clinical and preclinical experience

396 MGCD265, an orally active Met/VEGFR multitargeted kinase inhibitor, in combination with docetaxel: clinical and preclinical experience

45 or 50 Gy, Which is the Optimal Radiotherapy Pelvic Dose in Locally Advanced Cervical Cancer in the Perspective of Reaching Magnetic Resonance Image-guided Adaptive Brachytherapy Planning Aims?

5-Fluorouracil with Folinic Acid is Not Effective Against Metastatic Adenocarcinoma of the Lung

6998 Giant Pheochromocytoma: A Retrospective Single-Center Study

702PSTANDARD CLINICAL PRACTICE OF FOLFIRINOX (FFX) IN ADVANCED/METASTATIC PANCREATIC CANCER (PC) PATIENTS: A CANADIAN RETROSPECTIVE REGISTRY

Abstract 1790: The combination of MGCD265, a Met/VEGFR inhibitor in clinical development, and erlotinib potently inhibits tumor growth by altering multiple pathways including glycolysis

Abstract 3609: MGCD265, an orally active Met/VEGFR multitargeted kinase inhibitor in Phase II clinical development, potently inhibits clinically relevant Met mutants

Abstract 3610: Potent preclinical anti-tumor activity of MGCD265, an oral Met/VEGFR multitargeted kinase inhibitor in clinical development, in combination with taxanes

Abstract 3612: Potent preclinical anti-tumor activity of MGCD265, an orally active Met/VEGFR multitargeted kinase inhibitor in Phase II clinical development, in combination with an EGFR inhibitor

Abstract 4681: Inhibition of poly (ADP-ribose) polymerase-1 (PARP-1) as a strategy for targeted therapy in Ewing's sarcoma

Abstract 930: Preclinical characterization of MG516, a novel inhibitor of receptor tyrosine kinases involved in resistance to targeted therapies

Abstract A95: The determination of the maximum tolerated dose (MTD) of MGCD265 on an intermittent schedule: Phase I study results (Study 265-102)

Abstract No. 124 Quantitative analysis of tissue contraction and volume variability of lung microwave ablation zones

Acute hypersensitivity of pluripotent testicular cancer-derived embryonal carcinoma to low-dose 5-aza deoxycytidine is associated with global DNA Damage-associated p53 activation, anti-pluripotency and DNA demethylation

Acute Kidney Injury and Bronchopulmonary Dysplasia in Premature Neonates Born Less than 32 Weeks' Gestation

Acute Kidney Injury is Associated with Poor Lung Outcomes in Infants Born ≥32 Weeks of Gestational Age

Adjuvant chemotherapy with fluorouracil plus folinic acid vs gemcitabine following pancreatic cancer resection: a randomized controlled trial

ADM1 performance using SS-OFMSW with non-acclimated inoculums

Admetal-induced substrate surface restructuring during metal-on-metal electrochemical deposition studied by in situ scanning tunneling microscopy

Advances in Neonatal Acute Kidney Injury

Suchergebnisse filtern